}

Arab Pharmaceuticals logs 16% YoY higher profits in FY2025/26

Updated 8/2/2026 12:25:00 PM
Arab Pharmaceuticals logs 16% YoY higher profits in FY2025/26

Arab Finance: The net profits after tax of Arab Pharmaceuticals Company jumped by 16% year-on-year (YoY) to EGP 263.594 million in fiscal year (FY) 2025/2026 from EGP 227.858 million, according to the financial results.

Likewise, net sales hiked by 23% YoY to EGP 1.37 billion at the end of June 2026 from EGP 1.11 billion.

Basic earnings per share (EPS) increased to EGP 19.17 from EGP 17.07.

In the first half (H1) of FY2025/2026, the net profits after tax soared by 127% YoY to EGP 134.551 million from EGP 106.005 million.

Related News